GlassScriptPhysician profile
Joseph Reid Weber
NPI 1194218396
$721.48
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $94.18 · 2022: $120 · 2023: $372 · 2024: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $131.67 | 2022-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $109.28 | 2021-2023 | Brilinta |
| Pfizer INC. | $79.93 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $72.24 | 2024 | Camzyos |
| Merck Sharp & Dohme LLC | $66.47 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $65.59 | 2021-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $50.19 | 2024 | |
| Novo Nordisk INC | $40.77 | 2023 | |
| Cardiva Medical, INC. | $30.41 | 2023 | Cardiva Vascade 6/7f Vcs |
| Edwards Lifesciences Corporation | $22.68 | 2023 | Sapien 3 Ultra Resilia |
| Acist Medical Systems, INC. | $19.00 | 2021 | |
| Zoll Circulation INC | $17.94 | 2023 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Lantheus Medical Imaging, INC. | $15.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.